Report cover image

Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report

Publisher MarketLine
Published Jan 28, 2022
Length 59 Pages
SKU # MTLN16999834

Description

Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report

Summary

Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hikma Pharmaceuticals PLC (Hikma or 'the company') is a developer, manufacturer and marketer of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including: anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various forms such as injectable, oral and other non-injectable generic products. The company markets its products through sales and marketing teams. Its major customers in the US and Europe include pharmacy chains, wholesalers, governments and hospital purchasing organizations. Hikma markets products to doctors and pharmacists in Middle East and North Africa region through its representatives. The company primarily operates in the Middle East and North Africa, the US, and Europe. The company is headquartered in London, Greater London, the UK

Scope
  • Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
  • An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
  • Intelligence on Hikma Pharmaceuticals PLC's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Hikma Pharmaceuticals PLC's business structure, strategy and prospects.

Table of Contents

59 Pages
Company Snapshot
Hikma Pharmaceuticals PLC: Company Overview
Hikma Pharmaceuticals PLC: Overview and Key Facts
Hikma Pharmaceuticals PLC: Overview
Hikma Pharmaceuticals PLC: Key Facts
Hikma Pharmaceuticals PLC: Key Employees
Hikma Pharmaceuticals PLC: Key Employee Biographies
Hikma Pharmaceuticals PLC: Major Products and Services
Hikma Pharmaceuticals PLC: Company History
Hikma Pharmaceuticals PLC: Management Statement
Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Hikma Pharmaceuticals PLC: Key Competitors
Hikma Pharmaceuticals PLC: Company Analysis
Hikma Pharmaceuticals PLC: Business Description
Hikma Pharmaceuticals PLC: SWOT Analysis
Hikma Pharmaceuticals PLC: SWOT Overview
Hikma Pharmaceuticals PLC: Strengths
Hikma Pharmaceuticals PLC: Weaknesses
Hikma Pharmaceuticals PLC: Opportunities
Hikma Pharmaceuticals PLC: Threats
Hikma Pharmaceuticals PLC: Corporate Financial Deals Activity
Hikma Pharmaceuticals PLC: Financial Deals Overview
Hikma Pharmaceuticals PLC: Targets and Partners
Hikma Pharmaceuticals PLC: Top Deals 2018 - 2022YTD*
Hikma Pharmaceuticals PLC: Advisors
Hikma Pharmaceuticals PLC: Top Legal Advisors
Hikma Pharmaceuticals PLC: Top Financial Advisors
Hikma Pharmaceuticals PLC: Mergers and Acquisitions
Hikma Pharmaceuticals PLC: Capital Raising
Hikma Pharmaceuticals PLC: Partnership
Hikma Pharmaceuticals PLC: Recent Developments
Hikma Pharmaceuticals PLC: News and Events Summary
Hikma Pharmaceuticals PLC: Business Expansion
Hikma Pharmaceuticals PLC: Corporate Governance
Hikma Pharmaceuticals PLC: Financial Performance
Hikma Pharmaceuticals PLC: Market Developments
Hikma Pharmaceuticals PLC: Research & Development
Hikma Pharmaceuticals PLC: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Hikma Pharmaceuticals PLC: Key Facts
Table 2: Hikma Pharmaceuticals PLC: Key Employees
Table 3: Hikma Pharmaceuticals PLC: Company History
Table 4: Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Table 5: Hikma Pharmaceuticals PLC: Key Competitors
Table 6: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Table 9: Hikma Pharmaceuticals PLC: Targets and Partners
Table 10: Hikma Pharmaceuticals PLC: Top Deals 2018 - 2022YTD*
Table 11: Hikma Pharmaceuticals PLC: Legal Advisor Ranking by Value (US$m)
Table 12: Hikma Pharmaceuticals PLC: Financial Advisor Ranking by Value (US$m)
Table 13: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2018 - YTD*2022)
Table 14: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2018 - YTD*2022)
Table 15: Hikma Pharmaceuticals PLC: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 16: Hikma Pharmaceuticals PLC: Capital Raising by Deal Type (2018 - YTD*2022)
Table 17: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 18: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 19: Hikma Pharmaceuticals PLC: News and Events Summary
Table 20: Hikma Pharmaceuticals PLC: Business Expansion
Table 21: Hikma Pharmaceuticals PLC: Corporate Governance
Table 22: Hikma Pharmaceuticals PLC: Financial Performance
Table 23: Hikma Pharmaceuticals PLC: Market Developments
Table 24: Hikma Pharmaceuticals PLC: Research & Development
Table 25: Hikma Pharmaceuticals PLC: Strategy and Operations
List of Figures
Figure 1: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Figure 4: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 5: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2018 - YTD*2022)
Figure 6: Hikma Pharmaceuticals PLC: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 7: Hikma Pharmaceuticals PLC: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 8: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 9: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2018 - YTD*2022)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us